Publikationen

04 Publikationen

22 23

Originalarbeiten

1. Aeschbacher S, O'Neal WT, Krisai P, Loehr L, Chen LY, Alonso A, Soliman EZ, Conen D. Relationship between QRS duration and incident atrial fibrillation. Int J Cardiol. 2018. Impact Factor 4.034

2. Akiyama E, Van Aelst LNL, Arrigo M, Lassus J, Mir— ñ, Celutkiene J, Choi DJ, Cohen-Solal A, Ishihara S, Kajimoto K, Laribi S, Maggioni AP, Motie-junaite J, Mueller C, Parenica J, Park JJ, Sato N, Spinar J, Zhang J, Zhang Y, Kimura K, Tamura K, Gayat E, Mebazaa A; GREAT (Global Research on Acute Conditions Team) Network. East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort. Eur J Heart Fail. 2018. Impact Factor 10.683

3. Ambavane A, Lindahl B, Giannitis E, Roiz J, Mendivil J, Frankenstein L, Body R, Christ M, Bingisser R, Alquezar A, Mueller C; TRAPID-AMI investi-gators. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department. PLoS One. 2018. Impact Factor 2.766.

4. Arslani K, Roffler N, Zurek M, Greutmann M, Schwerzmann M, et al. Patterns of Incidence Rates of Cardiac Complications in Patients With Con-genital Heart Disease. Can J Cardiol. 2018. Impact Factor 4.524

5. Arslani K, Notz L, Zurek M, Greutmann M, Schwerzmann M, et al. Anticoagulation practices in adults with congenital heart disease and atrial arrhythmias in Switzerland. Congenit Heart Dis. 2018. Impact Factor 1.995

6. Badertscher P, Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Sabti Z, Puelacher C, Rubini Gim�nez M, PfŠffli J, Flores D, du Fay de La-vallaz J, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Lohrmann J, Buser A, Keller DI, Geigy N, Reichlin T, Mueller C. Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin. Clin Chem. 2018. Impact Factor 8.636

7. Badertscher P, Boeddinghaus J, Twerenbold R, Nestelberger T, Wildi K, Wussler D, Schwarz J, Puelacher C, Rubini Gim�nez M, Kozhuharov N, du Fay de Lavallaz J, Cerminara SE, Potlukova E, Rentsch K, Mir— ñ, L—pez B, Martin-Sanchez FJ, Morawiec B, Muzyk P, Keller DI, Reich-lin T, Mueller C; APACE Investigators. Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

8. Badertscher P, Strebel I, Honegger U, Schaerli N, Mueller D, Puelacher C, Wagener M, AbŠcherli R, Walter J, Sabti Z, Sazgary L, Marbot S, du Fay de Lavallaz J, Twerenbold R, Boeddinghaus J, Nestelberger T, Kozhuharov N, Breidthardt T, Shrestha S, Flores D, Schumacher C, Wild D, Osswald S, Zellweger MJ, Mueller C, Reichlin T. Automatically computed ECG algorithm for the quantification of myocardial scar and the prediction of mortality. Clin Res Cardiol. 2018. Impact Factor 4.455

9. Becher PM, Schrage B, Sinning CR, Schmack B, Fluschnik N, Schwarzl M, Waldeyer C, Lindner D, Seiffert M, Neumann JT, Bernhardt AM, Zeymer U, Thiele H, Reichenspurner H, Blankenberg S, Twerenbold R, Westermann D. Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmo-nary Support. Circulation. 2018. Impact Factor 18.88

10. Beri N, Daniels LB, Jaffe A, Mueller C, Anand I, Peacock WF, Hollander JE, DeFilippi C, Schreiber D, McCord J, Limkakeng AT, Wu AHB, Apple FS, Diercks DB, Nagurney JT, Nowak RM, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A. Copeptin to rule out myo-cardial infarction in Blacks versus Caucasians. Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

11. Bernasconi R, Aeschbacher S, Blum S, Mongiat M, Girod M, Todd J, Estis J, Nolan N, Renz H, Risch L, Conen D, Risch M. Fibroblast growth factor 23 and renal function among young and healthy individuals. Clin Chem Lab Med. 2018. Impact Factor 3.556

12. Biasco L, Radovanovic D, Moccetti M, Rickli H, Roffi M, Eberli F, Jeger R, Moccetti T, Erne P, Pedrazzini G. New-onset or Pre-existing Atrial Fibrilla-tion in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. Rev Esp Cardiol (Engl Ed). 2018. Impact Factor 5.166

13. Boeddinghaus J, Nestelberger T, Twerenbold R, Neumann JT, Lindahl B, Giannitsis E, S¿rensen NA, Badertscher P, Jann JE, Wussler D, Puelacher C, Rubini Gim�nez M, Wildi K, Strebel I, Du Fay de Lavallaz J, Selman F, Sabti Z, Kozhuharov N, Potlukova E, Rentsch K, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Parenica J, Lohrmann J, Kloos W, Buser A, Geigy N, Keller DI, Osswald S, Reichlin T, Westermann D, Blankenberg S, Mueller C; APACE, BACC, and TRAPID-AMI Investigators. Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction. Eur Heart J. 2018. Impact Factor 23.425

14. Boeddinghaus J, Twerenbold R, Nestelberger T, Badertscher P, Wildi K, Puelacher C, du Fay de Lavallaz J, Keser E, Rubini Gim�nez M, Wussler D, Kozhuharov N, Rentsch K, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Stefanelli S, Geigy N, Keller DI, Reichlin T, Mueller C; APACE Investigators. Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. Clin Chem. 2018. Impact Factor 8.636

15. Brasier N, Engelter S, Kolbitsch T, Tabord A, Knobeloch J, KŸhne M, Conen D, Traenka C, Kreutzberger T, Všllmin G, Eckstein J. The quest for indicators of paroxysmal atrial fibrillation in sinus rhythm - the DETECT AF trial. Acta Cardiol. 2018. Impact Factor 0.876

16. Breidthardt T, Brunner-Schaub N, Balmelli C, Insenser JJS, Burri-Winkler K, Geigy N, Mundorff L, Exadaktylos A, Scholz J, Haaf P, Hamel C, Frey D, Delport K, Peacock WF, Freese M, DiSomma S, Todd J, Rentsch K, Bingisser R, Mueller C; BASEL VII Investigators. Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain. Clin Chem. 2018. Impact Factor 8.636

17. Breidthardt T, Jaeger C, Christ A, Klima T, Mosimann T, Twerenbold R, Boeddinghaus J, Nestelberger T, Badertscher P, Struck J, Bergmann A, Hartmann O, Kalbermatter S, Marenzi G, Mueller C. Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease. Eur J Clin Invest. 2018. Impact Factor 3.086

18. Breidthardt T, Moreno-Weidmann Z, Uthoff H, Sabti Z, Aeppli S, Puelacher C, Stallone F, Twerenbold R, Wildi K, Kozhuharov N, Wussler D, Flores D, Shrestha S, Badertscher P, Boeddinghaus J, Nestelberger T, Gimenez MR, Staub D, Aschwanden M, Lohrmann J, Pfister O, Osswald S, Mueller C. How accurate is clinical assessment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study. Eur J Heart Fail. 2018. Impact Factor 10.683

19. Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, Buser P, Zellweger MJ. The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography. PLoS One. 2018. Impact Factor 2.766

20. Chandrasekhar J, Baber U, Sartori S, Stefanini GG, Sarin M, Vogel B, Farhan S, Camenzind E, Leon MB, Stone GW, Serruys PW, Wijns W, Steg PG, Weisz G, Chieffo A, Kastrati A, Windecker S, Morice MC, Smits PC, von Birgelen C, Mikhail GW, Itchhaporia D, Mehta L, Kim HS, Valgimigli M, Jeger RV, Kimura T, Galatius S, Kandzari D, Dangas G, Mehran R. Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Under-going Percutaneous Coronary Intervention WithNew-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. JACC Cardiovasc Interv. 2018. Impact Factor 9.881

21. Conen D, Rodondi N, Mueller A, Beer JH, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, SchlŠpfer J, Di Valentino M, Aeschbacher S, Blum S, Meyre P, Sticherling C, Bonati LH, Ehret G, Moutzouri E, Fischer U, Monsch AU, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, KŸhne M, Osswald S for the Swiss AF study investigators. Relationships of Overt and Silent Brain Lesions with Cognitive Function in Patientswith Atrial Fibrillation. J Am Coll Cardiol. 2018. Impact Factor 16.834

22. Cupa J, Strebel I, Badertscher P, AbŠcherli R, Twerenbold R, Schumacher L, Boeddinghaus J, Nestelberger T, Maechler P, Kozhuharov N, Gim�nez MR, Wildi K, du Fay de Lavallaz J, Sabti Z, Sazgary L, Puelacher C, Mueller D, Bianci C, Mir— ñ, Fuenzalida C, Calder—n S, Mart’n-S‡nchez FJ, Iglesias SL, Morawiec B, Kawecki D, Parenica J, Keller DI, Geigy N, Osswald S, Mueller C, Reichlin T. Diagnostic and prognostic value of QRS duration and QTc interval in patients with suspected myocardial infarction. Cardiol J. 2018. Impact Factor 1.339

23. Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Goronek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumara K, Piccini JP, Potpara T, Klindt Poulsen B, Saba M, Savelieva I, Tamargo JL, Wolpert C, SticherlingC, Ehrlich JR, Schilling R, Pavlovic N, De Potter T, Lubinski A, Hastrup Svendsen J, Ching K, Sapp JL, Chen-Scarabelli C, Martinez F. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) working group on Cardiovascular Pharmacology. Europace. 2018. Impact Factor 5.231

24. De Boeck BW, Toma A, Kiencke S, Dehnert C, ZŸgel S, Siebenmann C, Auinger K, Buser PT, Maggiorini M, Kaufmann BA. Altered left ventricular geometry and torsional in high altitude-induced pulmonary hypertension: a 3D echocardiographic study. J Am Soc Echocardiogr. 2018. Impact Factor 6.827

25. De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, Porto I, Crea F, Dall'Armellina E Channon KM, Kharbanda RK, Banning AP. Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI. JACC Cardiovasc Imaging. 2018. Impact Factor 10.247

26. de Waard GA, Fahrni G, de Wit D, Kitabata H, Williams R, Patel N, Teunissen PF, van de Ven PM, Umman S, Knaapen P, Perera D, Akasaka T, Sezer M, Kharbanda RK, van Royen N; Oxford Acute Myocardial Infarction (OxAMI) Study investigators. Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction. Heart. 2018. Impact Factor 5.42

27. du Fay de Lavallaz J, Badertscher P, Nestelberger T, Flores D, Mir— ñ, Salgado E, Geigy N, Christ M, Cullen L, Than M, Martin-Sanchez FJ, Rodriguez-Adrada E, Di Somma S, Peacock WF, Kawecki D, Boeddinghaus J, Twerenbold R, Puelacher C, Wussler D, Strebel I, Keller DI, Poepping I, KŸhne M, Reichlin T, Mueller C; BASEL IX Investigators . Circadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncope. Europace. 2018. Impact Factor 5.231

28. du Fay de Lavallaz J, Badertscher P, Nestelberger T, Isenrich R, Mir— ñ, Salgado E, Geigy N, Christ M, Cullen L, Than M, Martin-Sanchez FJ, Bustamante Mandri—n J, Di Somma S, Peacock WF, Kawecki D, Boeddinghaus J, Twerenbold R, Puelacher C, Wussler D, Strebel I, Keller DI, Poep-ping I, Kühne M, Mueller C, Reichlin T; BASEL IX Investigators, Gim�nez MR, Walter J, Kozhuharov N, Shrestha S, Mueller D, Sazgary L, Morawiec B, Muzyk P, Nowalany-Kozielska E, Freese M, Stelzig C, Meissner K, Kulangara C, Hartmann B, Ferel I, Sabti Z, Greenslade J, Hawkins T, Rentsch K, von Eckardstein A, Buser A, Kloos W, Lohrmann J, Osswald S. Prospective validation of prognostic and diagnostic syncope scores in the emergency department. Int J Cardiol. 2018. Impact Factor 4.034

29. du Fay de Lavallaz J, Puelacher C, Lurati Buse G, Bolliger D, Germanier D, Hidvegi R, Walter JE, Twerenbold R, Strebel I, Badertscher P, Sazgary L, Lampart A, Espinola J, Kindler C, Hammerer-Lercher A, Thambipillai S, Guerke L, Rentsch K, Buser A, Gualandro D, Jakob M, Mueller C; BASEL-PMI Investigators. Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect onoutcome. Heart. 2018. Impact Factor 5.42

30. du Fay de Lavallaz J, Zehntner T, Puelacher C, Walter J, Strebel I, Rentsch K,Boeddinghaus J, Nestelberger T, Twerenbold R, Mueller C. Rhab-domyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T? J Am Coll Cardiol. 2018. Impact Factor 16.834

31. Eggimann L, Blum S, Aeschbacher S, Reusser A, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Mondet N, KŸhne M, Sticherling C, Osswald S, Conen D. Risk factors for heart failure hospitalizations among patients with atrial fibrillation. PLoS One. 2018.Impact Factor 2.766

32. Egli P, Aeschbacher S, Bossard M, Eggimann L, Blum S, Meyre P, Bargetzi L, Estis J, Todd J, Risch M, Risch L, Conen D. Relationships of kidney injury molecule-1 with renal function and cardiovascular risk factors in the general population. Clin Chim Acta. 2018. Impact Factor 2.926

33. Faggioni M, Baber U, Afshar AE, Giustino G, Sartori S, Sorrentino S, Steg PG, Stefanini GG, Windecker S, Leon MB, Stone GW, Wijns W, Ser-ruys PW, Valgimigli M, Camenzind E, Weisz G, Smits PC, Kandzari DE, Galatius S, Von Birgelen C, Jeger RV, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Dangas GD, Morice MC, Mehran R. Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2018.Impact Factor 9.881

34. Filipovic MG, Aeschbacher S, Reiner MF, Stivala S, Gobbato S, Bonetti N, Risch M, Risch L, Camici GG, Luescher TF, von Schacky C, Conen D, Beer JH. Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young and healthy adults. J Hypertens. 2018. Impact Factor 4.092

35. Garg P, Aziz R, Al Musa T, Ripley DP, Haaf P, Foley JRJ, Swoboda PP, Fent GJ, Dobson LE, Greenwood JP, Plein S. Effects of hyperaemia on left ventricular longitudinal strain in patients with suspected coronary artery disease : A first-pass stress perfusion cardiovascular magnetic resonance imaging study. Neth Heart J. 2018. Impact Factor 1.476

Publikationen

04 Publikationen

24 25

36. Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, MŸnzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jagus-zewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschšpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimsk� P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Bšhm M, LŸscher TF, Ruschitzka F, Templin C. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018. Impact Factor 16.834

37. Gilgen N, Farah A, Scheller B, Ohlow MA, Mangner N, Weilenmann D, Wšhrle J, Jamshidi P, Leibundgut G, Mšbius-Winkler S, Zweiker R, Krack-hardt F, Butter C, Bruch L, Kaiser C, Hoffmann A, Rickenbacher P, Mueller C, Stephan FP, Coslovsky M, Jeger R; BASKET-SMALL 2 Investigators. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2. Clin Cardiol. 2018. Impact Factor 2.733

38. Gualandro DM, Puelacher C, LuratiBuse G, Lampart A, Strunz C, Cardozo FA, Yu PC, Jaffe AS, Barac S, Bock L, Badertscher P, du Fay de Lavallaz J, Marbot S, Sazgary L, Bolliger D, Rentsch K, Twerenbold R, Hammerer-Lercher A, Melo ES, Calderaro D, Duarte AJ, de Luccia N, Caramelli B, Mu-eller C; TropoVasc and BASEL-PMI Investigators. Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery. Am Heart J. 2018. Impact Factor 4.171

39. Gunten SV, Theuns DA, KŸhne M, Reichlin T, Sticherling C, Schaer B. Predictors for early mortality and arrhythmic events in patients with a CRT-D: a two center cohort study. Cardiol J. 2018. Impact Factor 1.339

40. Hern‡ndez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Ja-nousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K; Sticherling C, Kautzner J, Wissner E, Sommer P, Gupta D, Szili-Torok T, Tateno S, Alfaro A, Budts W, Gallego P, Schwerzmann M, Milanesi O, Sarquella-Brugada G, Kornyei L, Sreeram N, Drago F, Dubin A. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018. Impact Factor 5.231

41. Iglesias JF, Muller O, Zaugg S, Roffi M, Kurz DJ, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, JŸni P, Windecker S, Pilgrim T. A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. EuroIntervention. 2018. Impact Factor 4.417

42. Jeger R, Reuthebuch O, Fahrni G, Laborde JC, Vogel R, Kaiser C. Supra-annular sizing for transcatheter valve implantation in bicuspid aortic stenosis. Postepy Kardiol Interwencyjnej. 2018. Impact Factor 1.443

43. Jeger R, Farah A, Ohlow MA, Mangner N, Mšbius-Winkler S, Leibundgut G, Weilenmann D, Wšhrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Chandrasekhar N, Osswald S, Kaiser C, Scheller B; BASKET-SMALL 2 Investigators. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018.Impact Factor 53.254

44. Johannes J, Greutmann M, Tobler D, Bouchardy J, Stambach D, et al. The impact of trisomy 21 on treatment modalities and outcome in adults with congenital heart disease in Switzerland. Pulm Circ. 2019. Impact Factor 2.178

45. Kamber F, Mauermann E, Seeberger E, Guerke L, Mueller C, Bolliger D, Lurati Buse GAL. Peri-operative copeptin concentrations and their associ-ation with myocardial injury after vascular surgery: A prospective observational cohort study. Eur J Anaesthesiol. 2018. Impact Factor 3.958

46. Knecht S, Pradella M, Reichlin T, MŸhl A, Bossard M, Stieltjes B, Conen D, Bremerich J, Osswald S, KŸhne M, Sticherling C. Left atrial anatomy, atrial fibrillation burden and P-wave duration - relationships and predictors for single procedure success after pulmonary vein isolation. Europace. 2018. Impact Factor 5.231

47. Knecht S, Brantner P, Cattin P, Tobler D, KŸhne M, et al. State-of-the-art multimodality approach to assist ablations in complex anatomies-From 3D printing to virtual reality. Pacing Clin Electrophysiol. 2019. Impact Factor 1.441

48. Knecht S, Burch F, Reichlin T, Spies F, MŸhl A, Altmann D, Ammann P, Schaer B, Osswald S, Sticherling C, KŸhne M. First clinical experience of a dedicated irrigated-tip radiofrequency ablation catheter for the ablation of cavotricuspid isthmus-dependent atrial flutter. Clin Res Cardiol 2018. Impact Factor 4.455

49. Koskinas KC, Windecker S, Buhayer A, Gencer B, Pedrazzini G, Mueller C, Cook S, Muller O, Matter CM, RŠber L, Heg D, Mach F; EVOPACS Investigators. Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial. Clin Cardiol. 2018. Impact Factor 2.733

50. Kuck KH, Brugada J, FŸrnkranz A, Chun KRJ, Metzner A, Ouyang F, SchlŸter M, Elvan A, Braegelmann KM, Kueffer FJ, Arentz T, Albenque JP, KŸhne M, Sticherling C, Tondo C; FIRE AND ICE Investigators. Impact of Female Sex on Clinical Outcomes in the FIRE AND ICE Trial of Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2018. Impact Factor 4.712

51. Legrand M, Ludes PO, Massy Z, Rossignol P, Parenica J, Park JJ, Ishihara S, AlHabib KF, Maggioni A, Mir— ñ, Sato N, Cohen-Solal A, Fairman E, Lassus J, Harjola VP, Mueller C, Peacock FW, Choi DJ, Plaisance P, Spinar J, Kosiborod M, Mebazaa A, Gayat E; GREAT (Global Research on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists) network. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. 2018.Impact Factor 4.455

52. Linde C, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G, Sticherling C, Bulava A, Cano O, Maas A, Witte KK, Rekvava R, Abdelali S, Dickstein K. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the ESC CRT Survey II. Eur J Heart Fail. 2018. Impact Factor 10.683

53. Mangione FM, Biering-S¿rensen T, Nochioka K, Jatene T, Silvestre OM, Hansen KW, S¿rensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials. Catheter Cardiovasc Interv. 2018. Impact Factor 2.602

54. McIntyre WF, Conen D, Olshansky B, Halperin JL, Hayek E, Huisman MV, Lip GYH, Lu S, Healey JS. Stroke-prevention strategies in North Ame-rican patients with atrial fibrillation: The GLORIA-AF registry program. Clin Cardiol. 2018. Impact Factor 2.733

55. Melly L, Cerino G, Frobert A, Cook S, Giraud MN, Carrel T, Tevaearai Stahel HT, Eckstein F, Rondelet B, Marsano A, Banfi A. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J Cell Mol Med. 2018. Impact Factor 4.302

56. Mir— ñ, Javaloyes P, Gil V, Mart’n-S‡nchez FJ, Jacob J, Herrero P, Marco-Hern‡ndez J, R’os J, Harjola VP, Torres-G‡rate R, Alonso MI, Pi–era P, Mecina AB, Escoda R, MŸller C, Parissis J, Llorens P; ICA-SEMES Research Group researchers. Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation. Am J Cardiol. 2018. Impact Factor 3.171

57. Mochizuki M, Della Verde G, Soliman H, Pfister O, Kuster GM. Induction of endothelial differentiation in cardiac progenitor cells under low serum conditions. J Vis Exp. Impact Factor 1.184

58. Mueller D, Puelacher C, Honegger U, Walter JE, Badertscher P, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Hollenstein C, du Fay de Lavallaz J, Jeger R, Kaiser C, Wild D, Rentsch K, Buser A, Zellweger M, Reichlin T, Mueller C. Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease. Clin Chem. 2018. Impact Factor 8.636

59. Mytsyk M, Isu G, Cerino G, Grapow MTR, Eckstein FS, Marsano A. Paracrine potential of adipose stromal vascular fraction cells to recover hypoxia-induced loss of cardiomyocyte function. Biotechnol Bioeng. 2018. Impact Factor 3.952

60. Nazerian P, Mueller C, de Matos Soeiro A, Leidel BA, Salvadeo SAT, Giachino F, Vanni S, Grimm K, Oliveira MT Jr, Pivetta EE, Lupia E, Grifoni S, Morello F; ADvISED Investigators. Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes: The ADvISED Prospective Multicenter Study. Circulation. 2018. Impact Factor 18.88

61. NDavarzani N, Sanders-van Wijk S, Maeder MT, Rickenbacher P, Smirnov E, Karel J, Suter T, de Boer RA, Bloch D, Rolny V, Zaugg C, Pfisterer ME, R. Peeters R, Brunner-La Rocca HP for the TIME-CHF Investigators. Novel concept to guide systolic heart failure medication by repeated bio-marker testing - results from TIME-CHF in context of predictive, preventive and personalized medicine. EPMA Journal. 2018.Impact Factor 3.900

62. Nebiker CA, Staubli S, SchŠfer J, Bingisser R, Christ-Crain M, Dell-Kuster S, Mueller C, Scamardi K, Viehl CT, Kolleth D, von Holzen U, Oertli D, Rosenthal R. Cortisol Outperforms Novel Cardiovascular, Inflammatory, and Neurohumoral Biomarkers in the Prediction of Outcome in Acute Pancreatitis. Pancreas. 2018. Impact Factor 2.958

63. Occhetta P, Isu G, Lemme M, Conficconi C, Oertle P, RŠz C, Visone R, Cerino G, Plodinec M, Rasponi M, Marsano A. A three-dimensional in vitro dynamic micro-tissue model of cardiac scar formation. Integr Biol (Camb). 2018. Impact Factor 3.294

64. Pilgrim T, Piccolo R, Heg D, Roffi M, TŸller D, Muller O, Moarof I, Siontis GCM, Cook S, Weilenmann D, Kaiser C, Cuculi F, Hunziker L, Eberli FR, JŸni P, Windecker S.Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet. 2018. Impact Factor 53.254

65. Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, Espinola J, Kindler C, Hammerer A, Seeberger E, Strebel I, Wildi K, Twerenbold R, du Fay de Lavallaz J, Steiner L, Gurke L, Breidthardt T, Rentsch K, Buser A, Gualandro D, Osswald S, Mueller C; BASEL-PMI Investi-gators. Perioperative myocardial injury after non-cardiac surgery: incidence, mortality and characterization. Circulation. 2018. Impact Factor 18.88

66. Puelacher C, Wagener M, Honegger U, Assadian M, Schaerli N, Mueller D, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Sabti Z, Sazgary L, Badertscher P, du Fay de Lavallaz J, Marbot S, Kaiser C, Wild D, Zellweger MJ, Reichlin T, Mueller C. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Clin Biochem. 2018. Impact Factor 2.434.

67. Reusser A, Blum S, Aeschbacher S, Eggimann L, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Manser S, Reichlin T, KŸhne M, Sticherling C, Osswald S, Conen D. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation. Int J Cardiol. 2018. Impact Factor 4.034

68. Rizas KD, Eick C, Doller AJ, Hamm W, von Stuelpnagel L, Zuern CS, Barthel P, Schmidt G, Bauer A. Bedside autonomic risk stratification after myocardial infarction by means of short-term deceleration capacity of heart rate. Europace. 2018. Impact Factor 5.231

69. Roselli C, Chaffin MD, Weng LC, Aeschbacher S et al., Multi-ethnic genome-wide association study for atrial fibrillation, Nat. Genet. 2018.Impact Factor 27.125

70. Rubini Gimenez M, Badertscher P, Twerenbold R, Boeddinghaus J, Nestelberger T, Wussler D, Mir— ñ, Martín-S‡nchez FJ, Reichlin T, Mueller C. Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

71. Ruperti Repilado FJ, Doerig L, Blum S, Aeschbacher S, Krisai P, Ammann P, Erne P, Moschovitis G, di Valentino M, Shah D, SchlŠpfer J, Stempfel S, KŸhne M, Sticherling C, Osswald S, Conen D. Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation. Swiss Med Wkly. 2018. Impact Factor 1.928

72. Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschin-ger M, Eckner D,Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke JT, Møller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Mšbius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S,Thiele H, SchŠfer A, Westermann D. Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Ana-lysis. Circulation. 2018. Impact Factor 18.88

73. Shahinian JH, Tobler D, Wolff T, Grapow M. Interrupted right-sided aortic arch: performance of umbilical xenograft after primary neonatal cor-rective surgery. J Thorac Dis. 2018 Impact Factor 2.365

74. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018. Impact Factor 79.258

Publikationen

04 Publikationen

26 27

75. Soeiro AM, Araœjo VA, Vella JP, Bossa AS, Biselli B, Leal TCAT, Soeiro MCFA, Serrano CV Jr, Mueller C, Oliveira Junior MT Is There Any Relati-onship between TSH Levels and Prognosis in Acute Coronary Syndrome? Arq Bras Cardiol. 2018. Impact Factor 1.318

76. Stamatelopoulos K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, Boeddinghaus J, Sopova K, Gatsiou A, Amrhein C, Biener M, Vafaie M, Athanasouli F, Stakos D, Pateras K, Twerenbold R, Badertscher P, Nestelberger T, Dimmeler S, Katus HA, Zeiher AM, Mueller C, Giannitsis E, Stellos K. Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study. Ann Intern Med. 2018. Impact Factor 19.384

77. Steinmann E, Brunner-La Rocca HP, Maeder MT, Kaufmann BA, Pfisterer M, Rickenbacher P. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction? Eur J Intern Med. 2018. Impact Factor 3.282

78. Sticherling C, Arendacka B, Svendsen J, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braun-schweig F, Svetoslak M, Zuern CS Huikuri H, Flevari, P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk, E, Eick C, Juntilla J, Conen D, Zabel M. Sex differences in outcomes of primary prevention implantable cardioverter defibrillator the-rapy: combined registry data from eleven European countries. Europace. 2018. Impact Factor 5.231

79. Sticherling C, MŸller D, Schaer BA, KrŸger S, Kolb C; Pre-CRAFT investigators Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy. Indian Pacing Electrophysiol 2018. Impact Factor 0.217

80. Stortecky S, Franzone A, Heg D, Tueller D, Noble S, Pilgrim T, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, GrŸnenfelder J, Muller O, Huber C, Roffi M, Carrel T, Wenaweser P, Windecker S. Temporal Trends in Adoption and Outcomes of Transcatheter Aortic Valve Implantation: A Swisstavi Registry Analysis. Eur Heart J Qual Care Clin Outcomes. 2018.

81. Strebel I, Twerenbold R, Boeddinghaus J, AbŠcherli R, Rubini Gim�nez M, Wildi K, Grimm K, Puelacher C, Badertscher P, Sabti Z, BreitenbŸcher D, Jann J, Selman F, du Fay de Lavallaz J, Schaerli N, Nestelberger T, Stelzig C, Freese M, Schumacher L, Osswald S, Mueller C, Reichlin T. Diag-nostic value of the cardiac electrical biomarker, a novel ECG marker indicating myocardial injury, in patients with symptoms suggestive of non-ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2018. Impact Factor 1.562

82. Strebel I, Twerenbold R, Wussler D, Boeddinghaus J, Nestelberger T, du Fay de Lavallaz J, AbŠcherli R, Maechler P, Mannhart D, Kozhuharov N, Rubini Gim�nez M, Wildi K, Sazgary L, Sabti Z, Puelacher C, Badertscher P, Keller DI, Mir— ñ, Fuenzalida C, Calder—n S, Martin-Sanchez FJ, Iglesias SL, Osswald S, Mueller C, Reichlin T. Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction. Int J Cardiol. 2018. Impact Factor 4.034

83. Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braun-schweig F, Svetlosak M, ZŸrn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M; EU-CERT-ICD Investigators. Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries. Europace. 2018. Impact Factor 5.231

84. Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators. One-Year Outcomes after PCI Strategies in Cardiogenic Shock. N Engl J Med. 2018. Impact Factor 79.258

85. Tigges E, Blankenberg S, von Bardeleben RS, ZŸrn C, Bekeredjian R, Ouarrak T, Sievert H, Nickenig G, Boekstegers P, Senges J, Schillinger W, Lubos E. Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve inter-ventions (TRAMI) registry. Eur J Heart Fail. 2018. Impact Factor 10.683

86. Trendelenburg M, Stallone F, Pershyna K, Eisenhut T, Twerenbold R, Wildi K, Dubler D,Schirmbeck L, Puelacher C, Rubini Gimenez M, Sabti Z, Osswald L, Breidthardt T, Mueller C. Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treat-ment and impacts on long-term survival. Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

87. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Puelacher C, Sabti Z, Rubini Gim�nez M, Tschirky S, du Fay de Lavallaz J, Kozhuharov N, Sazgary L, Mueller D, Breidthardt T, Strebel I, Flores Widmer D, Shrestha S, Mir— ñ, Mart’n-S‡nchez FJ, Morawiec B, Parenica J, Geigy N, Keller DI, Rentsch K, von Eckardstein A, Osswald S, Reichlin T, Mueller C. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2018. Impact Factor 18.88

88. Twerenbold R, Neumann JT, Sšrensen NA, Ojeda F, Karakas M, Boeddinghaus J, Nestelberger T, Badertscher P, Rubini Gim�nez M, Puelacher C, Wildi K, Kozhuharov N, Breitenbuecher D, Biskup E, du Fay de Lavallaz J, Flores D, Wussler D, Mir— ñ, Mart’n S‡nchez FJ, Morawiec B, Parenica J, Geigy N, Keller DI, Zeller T, Reichlin T, Blankenberg S, Westermann D, Mueller C. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. J Am Coll Cardiol. 2018. Impact Factor 16.834

89. van der Linden N, Wildi K, Twerenbold R, Pickering JW, Than M, Cullen L, Greenslade J, Parsonage W, Nestelberger T, Boeddinghaus J, Badert-scher P, Rubini Gim�nez M, Klinkenberg LJJ, Bekers O, Schšni A, Keller DI, Sabti Z, Puelacher C, Cupa J, Schumacher L, Kozhuharov N, Grimm K, Shrestha S, Flores D, Freese M, Stelzig C, Strebel I, Mir— ñ, Rentsch K, Morawiec B, Kawecki D, Kloos W, Lohrmann J, Richards AM, Troughton R, Pemberton C, Osswald S, van Dieijen-Visser MP, Mingels AM, Reichlin T, Meex SJR, Mueller C. Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

90. van der Stouwe JG, Carmeli C, Aeschbacher S, Schoen T, Krisai P, Wenger G, Ehret G, Ponte B, Pruijm M, Ackermann D, Guessous I, Paccaud F, Pech�re-Bertschi A, Vogt B, Mohaupt MG, Martin PY, Burnier M, Risch M, Risch L, Bochud M, Conen D. Association of 24-hour blood pressure with urinary sodium excretion in healthy adults. Am J Hypertens. 2018. Impact Factor 4.092

91. Walter JE, Honegger U, Puelacher C, Mueller D, Wagener M, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Sazgary L, Marbot S, de Lavallaz JDF, Kaiser C, Osswald S, Wild D, Rentsch K, Zellweger M, Reichlin T, Mueller C. Prospective Validation of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease. Clin Chem. 2018. Impact Factor 8.636

92. Whitehead N, Gill JF, Brink M and Handschin C. Moderate modulation of cardiac PGC-1alpha expression partially affects age-associated transcriptional remodeling of the heart. Frontiers in physiology. 2018. Impact Factor 2.089

93. Wildi K, Boeddinghaus J, Nestelberger T, Twerenbold R, Badertscher P, Wussler D, Gim�nez MR, Puelacher C, du Fay de Lavallaz J, Dietsche S, Walter J, Kozhuharov N, Morawiec B, Mir— ñ, Javier Martin-Sanchez F, Subramaniam S, Geigy N, Keller DI, Reichlin T, Mueller C; APACE investiga-tors. Comparison of fourteen rule-out strategies for acute myocardial infarction. Int J Cardiol. 2018. Impact Factor 4.034

94. Wildi K, Singeisen H, Twerenbold R, Badertscher P, Wussler D, Klinkenberg LJJ, Meex SJR, Nestelberger T, Boeddinghaus J, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Muzyk P, Parenica J, Keller DI, Geigy N, Potlukova E, Sabti Z, Kozhuharov N, Puelacher C, du Fay de Lavallaz J, Rubini Gimenez M, Shrestha S, Marzano G, Rentsch K, Osswald S, Reichlin T, Mueller C; APACE Investigators. Circadian rhythm of cardiac troponin I and its clinical impact on the diagnostic accuracy for acute myocardial infarction. Int J Cardiol. 2018. Impact Factor 4.034

95. Wuest S, Twerenbold R, KŸhne M, Reichlin T, Sticherling C, Osswald S, Schaer B. Reassessment of cardiovascular parameter and comorbidities in implantable cardoverter-defibrillator patients at the time of first replacement. Clin Cardiol. 2018. Impact Factor 2.733

96. Zabel M, Sticherling C, Rik Willems, Lubinski A, Bauer A, Bergau L, Braunschweig F, Brugada J, Brusich S, Conen D, Cygankiewicz I, Flevari P, Taborsky M, Hansen J, Hasenfuß G, Hatala R, Huikuri HV, KŠŠb S, Kaliska G, Kasprzak JD, LŸthje L, Malik M, Novotn� T, Pavlovic N, Schmidt G, Shalganov T, Sritharan R, Schlšgl SC, Szavits-Nossan J, Traykov V, Tuinenburg A, Velchev V, Vos MA, Willich SN, Friede T, Hastrup Svendsen J, Merkely B, for the EU-CERT-ICD Study Investigators. Rationale, Objectives and Design of the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) Prospective Study: Use of an Observational Controlled Study Design to Assess the Comparative Effectiveness of Primary Prophylactic ICD Implantation. ESC Heart Fail J. 2018. Impact Factor 10.683

97. Zeljkovic I, Burri H, Breitenstein A, Ammann P, Mueller A, Auricchio A, Delacr�taz E, Dickstein K, Linde C, Normand C, Sticherling C. Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe in Switzerland, Swiss Med Wkly. 2018. Impact Factor 1.928

98. Zellweger MJ, Tsirkin A, Vasilchenko V, Failer M, Dressel A, Kleber ME, Ruff P, MŠrz W. A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicine. EPMA J. 2018. Impact Factor 3.900

Reviews

1. Berger S, Meyre P, Blum S, Aeschbacher S, Ruegg M, Briel M, Conen D. Bariatric surgery among patients with heart failure: a systematic review and meta-analysis. Open Heart. 2018.

2. Blum S, Meyre P, Aeschbacher S, Berger S, Auberson C, Briel M, Osswald S, Conen D. Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis. Heart Rhythm. 2018. Impact Factor 4.743

3. Boehm K, Duckheim M, Mizera L, Groga-Bada P, Malek N, Kreth F, Gawaz M, Zuern CS, Eick C. Heart rate variability for rapid risk stratification of emergency patients with malignant disease. Support Care Cancer. 2018. Impact Factor 2.676

4. Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchro-nization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA. Europace. 2018. Impact Factor 5.231

5. Boriani G, Fauchier L, Aguinaga L, Beattie JM, Blomstrom Lundqvist C, Cohen A, Dan GA, Genovesi S, Israel C, Joung B, Kalarus Z, Lampert R, Malavasi VL, Mansourati J, Mont L, Potpara T, Thornton A, Lip GYH, Goronek B, Marin F, Dagres N, Ozcan EE, Lenarczyk R, Crijns HJ, Guo Y, Proietti M, Sticherling C, Huang D, Dauber JP, Pokorney SD, Ortega MC, Chin A. European Heart RhythmAssociation (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart RhythmSociety

6. Ebner M, Birschmann I, Peter A, HŠrtig F, Spencer C, Kuhn J, Rupp A, Blumenstock G, Zuern CS, Ziemann U, Poli S. Limitations of Specific Co-agulation Tests for Direct Oral Anticoagulants: A Critical Analysis. J Am Heart Assoc. 2018 Oct 2. Impact Factor 4.45

7. Eick C, Groga-Bada P, Reinhardt K, Duckheim M, Mizera L, Bšhm K, Gštz N, Gawaz M, ZŸrn C. Nocturnal respiratory rate as a predictor of mor-tality in patients with acute coronary syndrome. Open Heart. 2018.

8. Geis NA, Puls M, Lubos E, Zuern CS, Franke J, Schueler R, von Bardeleben RS, Boekstegers P, Ouarrak T, Zahn R, Ince H, Senges J, Katus HA, Bekeredjian R. Safety and efficacy of MitraClipª therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018. Impact Factor 10.683

9. Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschšpe C, de Boer RA. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018. Impact Factor 10.683

10. (APHRS),Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart RhythmSociety (LAHRS). Europace. 2018.Impact Factor 5.231

11. Harjola VP, Parissis J, Brunner-La Rocca HP, Celutkien� J, Chioncel O, Collins SP, De Backer D, Filippatos GS, Gayat E, Hill L, Lainscak M, Lassus J, Masip J, Mebazaa A, Mir— ñ, Mortara A, Mueller C, Mullens W, Nieminen MS, Rudiger A, Ruschitzka F, Seferovic PM, Sionis A, Vieillard-Baron A, Weinstein JM, de Boer RA, Crespo-Leiro MG, Piepoli M, Riley JP. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2018. Impact Factor 10.683

12. Hern‡ndez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Ja-nousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K; Sticherling C, Kautzner J, Wissner E, Sommer P, Gupta D, Szili-Torok T, Tateno S, Alfaro A, Budts W, Gallego P, Schwerzmann M, Milanesi O, Sarquella-Brugada G, Kornyei L, Sreeram N, Drago F, Dubin A. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018. Impact Factor 5.231

Publikationen

04 Publikationen

28 29

13. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kas-trati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk� P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018. Impact Factor 23.425

14. Jeger RV, Mšbius-Winkler S. Stents in saphenous vein grafts. Lancet. 2018. Impact Factor 53.254

15. Liu YC, Pfister O. How to diagnose heart failure? Ther Umsch. 2018.

16. Mair J, Lindahl B, Hammarsten O, Mueller C, Giannitsis E, Huber K, Mšckel M, Plebani M, Thygesen K, Jaffe AS. How is cardiac troponin re-leased from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

17. Masip J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, Maisel AS, Miro O, Filippatos G, Vrints C, Christ M, Cowie M, Platz E, McMurray J, DiSomma S, Zeymer U, Bueno H, Gale CP, Lettino M, Tavares M, Ruschitzka F, Mebazaa A, Harjola VP, Mueller C. Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J. 2018. Impact Factor 23.425

18. McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, PohjantŠhti-Maaroos H, Taylor J, Comin-Colet J. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018. Impact Factor 10.683

19. Mizera L, Boehm K, Duckheim M, Groga-Bada P, Gawaz M, Zuern CS, Eick C. Autonomic Nervous System Activity for Risk Stratification of Emergency Patients With Pneumonia. J Emerg Med. 2018 Oct. Impact Factor 1.207

20. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, JŸni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadar R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019. Impact Factor 23.425

21. Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, JŸni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019. Impact Factor 3.504

22. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, Mueller C. How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clin Biochem. 2018. Impact Factor 2.584

23. Walker DM, Gale CP, Lip G, Martin-Sanchez FJ, McIntyre HF, Mueller C, Price S, Sanchis J, Vidan MT, Wilkinson C, Zeymer U, Bueno H. Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

24. Zuern CS, Floss N, Mueller II, Eick C, Duckheim M, Patzelt J, Gawaz M, May AE, Mueller KAL. Galectin-3 is associated with left ventricular reverse remodeling and outcome after percutaneous mitral valve repair. Int J Cardiol. 2018. Impact Factor 4.034

Case Reports, eingeladene Reviews & Editorials

1. Aeschbacher S, Conen D. Healthy lifestyle and prevention of atrial fibrillation: Weighty matters. Eur J Prev Cardiol. 2018. Impact Factor 4.542

2. Haaf P, Kadner A, Tabbara S, Kessel-Schaefer A. Cavopulmonary window: case report of an unusual variant of a sinus venosus defect. European Heart Journal. 2018. Impact Factor 23.425

3. Kilian L, Haaf P, Pfister O, Vischer AS, Lapaire O, Burkard T. Reverse Takotsubo syndrome, a case report of a rare cause for postpartum heart failure. Cardiogenetics.

4. Knecht S, Brantner P, Cattin P, Tobler D, KŸhne M, Sticherling C. State-of-the-art multi-modality approach to assist ablations in complex anatomies - from 3D printing to virtual reality. Pacing Clin Electrophysiol. 2018. Impact Factor 1.441

5. Kozhuharov N, Madaffari A, Schaer B, Sticherling C. Kardiale Resynchronisationstherapie. info@herz+gefŠss. 2018.

6. Kozhuharov N, Sticherling C, SchŠr B. Device-Therapie bei Herzinsuffizienz. Therapeutische Umschau. 2018.

7. KŸhne M. Kartografie des Herzens mittels Mappingsystemen. Praxis (Bern 1994). 2018.

8. Perrin T, KŸhne M, Novak J. Positional pseudo-alternating bundle-branch-block on implantable loop recorder electrogram. Indian Pacing Elec-trophysiol J. 2018.

9. Rickenbacher P. Herzinsuffizienz - ein Dauerbrenner in Praxis und Spital. Therapeutische Umschau. 2018.

10. Rickenbacher P. Herzinsuffizienz mit "mid-range" Auswurffraktion: eine neue klinische EntitŠt? Therapeutische Umschau. 2018.

11. Zeljkovic I, Knecht S, Madaffari A, Mannhart D, Burri S, Germann A, Sticherling C, KŸhne M. Dual tachycardia involving the cavotricuspid isth-mus and Eustachian ridge. Cardiovasc Med. 2018. Impact Factor 1.67

12. Zeljkovic I, Knecht S, Sticherling C, KŸhne M. Wide and narrow QRS complex tachycardia with four different cycle lengths: What is the mecha-nism? Heart Rhythm. 2018. Impact Factor 4.743

13. Zellweger MJ. Despite some caveats: a normal myocardial perfusion result is still a strong value! Eur Heart J Cardiovasc Imaging. 2018.No abstract available. Impact Factor 23.425

Buchkapitel

Sticherling C, KŸhne M. Management of acute presentation with atrial fibrillation - rate control. In: Camm AJ, LŸscher TF, Maurer G, Serruys PW: ESC CardioMed (3 ed.). 2018.

Pfister O. Anemia and iron deficiency in heart failure. Heart Failure Text book, edited by Feldmann DS and Mohacsi P. Springer 171-178 (in press)

Letter to the editor

1. Dietsche SL, Breidthardt T, Kozhuharov N, Mueller C. Heart Failure: It Is Not Just Yes or No. J Am Coll Cardiol. 2018. Impact Factor 16.834

2. Gualandro DM, Caramelli B, Puelacher C, Mueller C. Reply. Cardiac troponin in vascular surgery. J Vasc Surg. 2018. Impact Factor 3.294

3. Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Rubini Gim�nez M, Wildi K, Hillinger P, Grimm K, Loeffel S, Shrestha S, Flores Widmer D, Cupa J, Kozhuharov N, Mir— ñ, Martín-S‡nchez FJ, Morawiec B, Rentsch K, Lohr-mann J, Kloos W, Osswald S, Reichlin T, Weber E, Marber M, Mueller C. Response by Kaier et al to Letter Regarding Article, Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

4. Morello F, Mueller C, Soeiro AM, Leidel BA, Salvadeo SAT, Nazerian P; ADvISED Investigators. Response by Morello et al to Letters Regarding Article, "Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndroms: The ADvISED Prospective Multicenter Study". Circulation. 2018. Impact Factor 18.88

5. Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Mueller C. Reply: Clarifying the Proper Definitions for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2018. Impact Factor 16.834

6. Nestelberger T, Boeddinghaus J, Mueller C. Letter by Nestelberger et al Regarding Article, Association Between Early Hyperoxia Exposure After Resuscitation from Cardiac Arrest and Neurological Disability: Prospective Multicenter Protocol-Directed Cohort Study. Circulation. 2018. Impact Factor 18.88

7. Nestelberger T, Boeddinghaus J, Mueller C. Type 2 myocardial infarction. Eur Heart J. 2018. Impact Factor 23.425

8. Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Mueller C. Reply: Clarifying the Proper Definitions for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2018. Impact Factor 16.834

9. Puelacher C, Mueller C. Response by Puelacher and Mueller to Letters Regarding Article, Perioperative Myocardial Injury After Noncardiac Sur-gery: Incidence, Mortality, and Characterization. Circulation. 2018. Impact Factor 18.88

10. Twerenbold R, Neumann JT, Blankenberg S, Westermann D, Mueller C. Reply: Hospital Charges Associated With Inpatient Troponin Testing. J Am Coll Cardiol. 2018. Impact Factor 16.834

11. Wein B, Kaiser C. Prasugrel vs clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts - Response to the letter to the Editor. Int J Cardiol. 2018. Impact Factor 4.034

12. Wussler D, du Fay de Lavallaz J, Mueller C. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. N Engl J Med. 2018. Impact Factor 79.258

13. Wussler D, Walter J, du Fay de Lavallaz J, Strebel I, Mueller C. Time to Diuretic in Acute Heart Failure. JACC Heart Fail. 2018. Impact Factor 8.202